A new cell treatment by Australian biotech Mesoblast has shown promising results in the treatment of rheumatoid arthritis. Researchers hope to conduct a phase 3 clinical trial as soon as possible.
Mesoblast Cell Treatment Offers Hope For Rheumatoid Arthritis Patients
Tech Times - 9 Aug 2016 08:12
A new cell treatment by Australian biotech Mesoblast has shown promising results in the treatment of rheumatoid arthritis. Researchers hope to conduct a phase 3 clinical trial as soon as possible.
Share this Article
Comment on this Article
Recommended
Please to comment